Literature DB >> 18032734

Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells.

Sergey Ryzhov1, Nataliya V Solenkova, Anna E Goldstein, Mathias Lamparter, Todd Fleenor, Pampee P Young, James P Greelish, John G Byrne, Douglas E Vaughan, Italo Biaggioni, Antonis K Hatzopoulos, Igor Feoktistov.   

Abstract

Intracoronary delivery of endothelial progenitor cells (EPCs) is an emerging concept for the treatment of cardiovascular disease. Enhancement of EPC adhesion to vascular endothelium could improve cell retention within targeted organs. Because extracellular adenosine is elevated at sites of ischemia and stimulates neovascularization, we examined the potential role of adenosine in augmenting EPC retention to cardiac microvascular endothelium. Stimulation of adenosine receptors in murine embryonic EPCs (eEPCs) and cardiac endothelial cells (cECs) rapidly, within minutes, increased eEPC adhesion to cECs under static and flow conditions. Similarly, adhesion of human adult culture-expanded EPCs to human cECs was increased by stimulation of adenosine receptors. Furthermore, adenosine increased eEPC retention in isolated mouse hearts perfused with eEPCs. We determined that eEPCs and cECs preferentially express functional A1 and A2B adenosine receptor subtypes, respectively, and that both subtypes are involved in the regulation of eEPC adhesion to cECs. We documented that the interaction between P-selectin and its ligand (P-selectin glycoprotein ligand-1) plays a role in adenosine-dependent eEPC adhesion to cECs and that stimulation of adenosine receptors in cECs induces rapid cell surface expression of P-selectin. Our results suggest a role for adenosine in vasculogenesis and its potential use to stimulate engraftment in cell-based therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032734      PMCID: PMC2803108          DOI: 10.1161/CIRCRESAHA.107.158147

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  27 in total

1.  Selectin GMP-140 (CD62; PADGEM) binds to sialosyl-Le(a) and sialosyl-Le(x), and sulfated glycans modulate this binding.

Authors:  K Handa; E D Nudelman; M R Stroud; T Shiozawa; S Hakomori
Journal:  Biochem Biophys Res Commun       Date:  1991-12-31       Impact factor: 3.575

2.  Vascular development in chick embryos: a possible role for adenosine.

Authors:  T H Adair; J P Montani; D M Strick; A C Guyton
Journal:  Am J Physiol       Date:  1989-01

3.  Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP.

Authors:  John H Cleator; Wen Qin Zhu; Douglas E Vaughan; Heidi E Hamm
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

4.  Purine nucleotides induce regulated secretion of von Willebrand factor: involvement of cytosolic Ca2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis.

Authors:  U M Vischer; C B Wollheim
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

5.  Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2).

Authors:  I Feoktistov; E M Garland; A E Goldstein; D Zeng; L Belardinelli; J N Wells; I Biaggioni
Journal:  Biochem Pharmacol       Date:  2001-11-01       Impact factor: 5.858

6.  Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors.

Authors:  Igor Feoktistov; Sergey Ryzhov; Anna E Goldstein; Italo Biaggioni
Journal:  Circ Res       Date:  2003-02-13       Impact factor: 17.367

7.  Blood donor white blood cell reduction filters as a source of human peripheral blood-derived endothelial progenitor cells.

Authors:  Amylynn A Teleron; Brian Carlson; Pampee P Young
Journal:  Transfusion       Date:  2005-01       Impact factor: 3.157

8.  Stimulation of endothelial adenosine A1 receptors enhances adhesion of neutrophils in the intact guinea pig coronary system.

Authors:  S Zahler; B F Becker; P Raschke; E Gerlach
Journal:  Cardiovasc Res       Date:  1994-09       Impact factor: 10.787

9.  Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis.

Authors:  M Carmen Montesinos; Jason P Shaw; Herman Yee; Peter Shamamian; Bruce N Cronstein
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

View more
  22 in total

1.  Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.

Authors:  Sebastian Michael; Heba Abdel-Aziz; Dieter Weiser; Christa E Müller; Olaf Kelber; Karen Nieber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-12-10       Impact factor: 3.000

2.  Ischemia induces P-selectin-mediated selective progenitor cell engraftment in the isolated-perfused heart.

Authors:  Jeremy Alan Elser; Brendan P Purcell; Irshad A Allana; Jason A Burdick; Kenneth B Margulies
Journal:  J Mol Cell Cardiol       Date:  2011-10-25       Impact factor: 5.000

Review 3.  Cell delivery routes for stem cell therapy to the heart: current and future approaches.

Authors:  Niall G Campbell; Ken Suzuki
Journal:  J Cardiovasc Transl Res       Date:  2012-05-31       Impact factor: 4.132

4.  Optimization of culture conditions for endothelial progenitor cells from porcine bone marrow in vitro.

Authors:  W Jianguo; L Tianhang; Z Hong; L Zhengmao; B Jianwei; X Xuchao; F Guoen
Journal:  Cell Prolif       Date:  2010-08       Impact factor: 6.831

Review 5.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

Review 6.  Coronary vessel development and insight towards neovascular therapy.

Authors:  Nicola Smart; Karina N Dubé; Paul R Riley
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

7.  2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.

Authors:  Edwin K Jackson; Jin Ren; Delbert G Gillespie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-27       Impact factor: 4.733

Review 8.  Hematopoietic stem cell homing to injured tissues.

Authors:  Dean Philip John Kavanagh; Neena Kalia
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

9.  Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.

Authors:  John Terrovitis; Riikka Lautamäki; Michael Bonios; James Fox; James M Engles; Jianhua Yu; Michelle K Leppo; Martin G Pomper; Richard L Wahl; Jurgen Seidel; Benjamin M Tsui; Frank M Bengel; M Roselle Abraham; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

Review 10.  Stem cell therapy: pieces of the puzzle.

Authors:  John A Schoenhard; Antonis K Hatzopoulos
Journal:  J Cardiovasc Transl Res       Date:  2009-11-19       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.